{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:29:50Z","timestamp":1772040590184,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Effective response to emerging pandemic threats is complicated by the need to develop specific vaccines and other medical products. The availability of broadly specific countermeasures that could be deployed early in the pandemic could significantly alter its course and save countless lives. Live attenuated vaccines (LAVs) were shown to induce non-specific protection against a broad spectrum of off-target pathogens by stimulating innate immune responses. The purpose of this study was to evaluate the effect of immunization with bivalent Oral Poliovirus Vaccine (bOPV) on the incidence of COVID-19 and other acute respiratory infections (ARIs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and Findings<\/jats:title><jats:p>A randomized parallel-group comparative study was conducted in Kirov Medical University. 1115 healthy volunteers aged 18 to 65 were randomized into two equal groups, one of which was immunized orally with a single dose of bOPV \u201cBiVac Polio\u201d and another with placebo. The study participants were monitored for three months for respiratory illnesses including COVID-19. The endpoint was the incidence of acute respiratory infections and laboratory confirmed COVID-19 in both groups during 3 months after immunization. The number of laboratory-confirmed cases of COVID-19 was significantly lower in the vaccinated group than in placebo (25 cases vs. 44, p=0.036). The difference between the overall number of clinically diagnosed respiratory illnesses in the two groups was not statistically significant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Immunization with bOPV reduced the number of laboratory-confirmed COVID-19 cases, consistent with the original hypothesis that LAVs induce non-specific protection against off-target infections. The findings are in line with previous observations of the protective effects of OPV against seasonal influenza and other viral and bacterial pathogens. The absence of a statistically significant effect on the total number of ARIs may be due to the insufficient number of participants and heterogeneous etiology of ARIs. OPV could be used to complement specific coronavirus vaccines, especially in regions of the world where the vaccines are unavailable, and as a stopgap measure for urgent response to future emerging infections. Clinical trial registration number NCT05083039 at clinicaltrals.gov <jats:uri>https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05083039?term=NCT05083039&amp;amp;draw=2&amp;amp;rank=1<\/jats:uri><\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.907341","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T06:11:52Z","timestamp":1654063912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Vaccination With Oral Polio Vaccine Reduces COVID-19 Incidence"],"prefix":"10.3389","volume":"13","author":[{"given":"Nadezhda V.","family":"Yagovkina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lev M.","family":"Zheleznov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ksenia A.","family":"Subbotina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey A.","family":"Tsaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liubov I.","family":"Kozlovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya V.","family":"Gordeychuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia K.","family":"Korduban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yury Y.","family":"Ivin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia A.","family":"Kovpak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia N.","family":"Piniaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna A.","family":"Shishova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Y.","family":"Shustova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf K.","family":"Khapchaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina G.","family":"Karganova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra A.","family":"Siniugina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana V.","family":"Pomaskina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr A.","family":"Erovichenkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Chumakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aydar A.","family":"Ishmukhametov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31142-9","article-title":"Physical Distancing, Face Masks, and Eye Protection to Prevent Person-To-Person Transmission of SARS-CoV-2 and COVID-19: A Systematic Review and Meta-Analysis","volume":"395","author":"Chu","year":"2020","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31183-1","article-title":"Physical Distancing, Face Masks, and Eye Protection for Prevention of COVID-19","volume":"395","author":"MacIntyre","year":"2020","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30742-X","article-title":"Vaccinology: Time to Change the Paradigm","volume":"20","author":"Benn","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.smim.2018.06.002","article-title":"Non-Specific Effects of Vaccines: Current Evidence and Potential Implications","volume":"39","author":"de Bree","year":"2018","journal-title":"Semin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.05.024","article-title":"Heterologous Effects of Vaccination and Trained Immunity","volume":"25","author":"Gyssens","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/003591573102401109","article-title":"Preventive Vaccination Against Tuberculosis With BCG","volume":"24","author":"Calmette","year":"1931","journal-title":"Proc R Soc Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix525","article-title":"Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 G: A Randomized Controlled Trial","volume":"65","author":"Biering-Sorensen","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"c6495","DOI":"10.1136\/bmj.c6495","article-title":"Non-Specific Effects of Standard Measles Vaccine at 4.5 and 9 Months of Age on Childhood Mortality: Randomised Controlled Trial","volume":"341","author":"Aaby","year":"2010","journal-title":"Bmj"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ617","article-title":"The Effect of Oral Polio Vaccine at Birth on Infant Mortality: A Randomized Trial","volume":"61","author":"Lund","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/ije\/dyw120","article-title":"Vaccinations Against Smallpox and Tuberculosis Are Associated With Better Long-Term Survival: A Danish Case-Cohort Study 1971-2010","volume":"46","author":"Rieckmann","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"100886","DOI":"10.1016\/j.eclinm.2021.100886","article-title":"National Immunisation Campaigns With Oral Polio Vaccine may Reduce All-Cause Mortality: Analysis of 2004-2019 Demographic Surveillance Data in Rural Bangladesh","volume":"36","author":"Nielsen","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.clinthera.2020.11.010","article-title":"Reduced Mortality After Oral Polio Vaccination and Increased Mortality After Diphtheria-Tetanus-Pertussis Vaccination in Children in a Low-Income Setting","volume":"43","author":"Oland","year":"2021","journal-title":"Clin Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.01.028","article-title":"Revaccination With Measles-Mumps-Rubella Vaccine and Hospitalization for Infection in Denmark and Sweden - An Interrupted Time-Series Analysis","volume":"40","author":"Sorup","year":"2021","journal-title":"Vaccine"},{"key":"B16","first-page":"37","article-title":"[Live Enteroviral Vaccines for the Emergency Nonspecific Prevention of Mass Respiratory Diseases During Fall-Winter Epidemics of Influenza and Acute Respiratory Diseases]","author":"Chumakov","year":"1992","journal-title":"Zhurnal Mikrobiol Epidemiol i Immunobiol \/"},{"key":"B17","first-page":"191","article-title":"Potential Use of Nonpathogenic Enteroviruses for Control of Human Disease","volume":"36","author":"Voroshilova","year":"1989","journal-title":"Prog Med Virol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix354","article-title":"Nonspecific Effects of Oral Polio Vaccine on Diarrheal Burden and Etiology Among Bangladeshi Infants","volume":"65","author":"Upfill-Brown","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.015","article-title":"Viral Interference Induced by Live Attenuated Virus Vaccine (OPV) can Prevent Otitis Media","volume":"29","author":"Seppala","year":"2011","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4262","article-title":"Can Existing Live Vaccines Prevent COVID-19","volume":"368","author":"Chumakov","year":"2020","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101718118","article-title":"Old Vaccines for New Infections: Exploiting Innate Immunity to Control COVID-19 and Prevent Future Pandemics","volume":"118","author":"Chumakov","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265562","article-title":"Use of Oral Polio Vaccine and the Incidence of COVID-19 in the World","volume":"17","author":"Habibzadeh","year":"2021","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2135044","DOI":"10.1001\/jamanetworkopen.2021.35044","article-title":"COVID-19 Infection Among Women in Iran Exposed vs Unexposed to Children Who Received Attenuated Poliovirus Used in Oral Polio Vaccine","volume":"4","author":"Habibzadeh","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B24","volume-title":"Manual for Virological Investigation of Poliomyelitis","year":"1997"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc2660","article-title":"The Specifics of Innate Immune Memory","volume":"368","author":"Dominguez-Andres","year":"2020","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining Trained Immunity and Its Role in Health and Disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.042","article-title":"Trained Immunity: A Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection","volume":"181","author":"Netea","year":"2020","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.08.011","article-title":"Developing the Concept of Beneficial Non-Specific Effect of Live Vaccines With Epidemiological Studies","volume":"25","author":"Aaby","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"B29","article-title":"Vaccine-Associated Paralytic Poliomyelitis Among Immune Deficient Persons (iVAPP): An Emerging Problem in the United States","volume-title":"32nd Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"Sutter","year":""},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-Derived Poliovirus (VDPV): Impact on Poliomyelitis Eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31279-6","article-title":"The Safety and Immunogenicity of Two Novel Live Attenuated Monovalent (Serotype 2) Oral Poliovirus Vaccines in Healthy Adults: A Double-Blind, Single-Centre Phase 1 Study","volume":"394","author":"Van Damme","year":"2019","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(20)32541-1","article-title":"Safety and Immunogenicity of Two Novel Type 2 Oral Poliovirus Vaccine Candidates Compared With a Monovalent Type 2 Oral Poliovirus Vaccine in Healthy Adults: Two Clinical Trials","volume":"397","author":"De Coster","year":"2021","journal-title":"Lancet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.907341\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T06:11:57Z","timestamp":1654063917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.907341\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2022.907341"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.907341","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]},"article-number":"907341"}}